MnDPDP enhancement in rabbit liver after intravenous bolus injection and slow infusion

Acta Radiologica

Volumn 38, Issue 4 PART 2, 1997, Pages 717-723

  Thorstensen, Örn ^a,b   Isberg, B ^a   Jorulf, H ^a   Westman, L ^a   Svahn, U ^a   Venizelos, N ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Diagnostic Radiology   (Iceland)

Author keywords

Enhancement, manganese; Experimental; Liver, contrast agents; Mr, mangafodipir trisodium

Indexed keywords

CONTRAST MEDIUM; DIAGNOSTIC AGENT; DRUG DERIVATIVE; EDETIC ACID; MANGANESE; N,N' BIS(PYRIDOXAL 5 PHOSPHATE)ETHYLENEDIAMINE N,N' DIACETIC ACID; N,N'-BIS(PYRIDOXAL-5-PHOSPHATE)ETHYLENEDIAMINE-N,N'-DIACETIC ACID; PYRIDOXAL 5 PHOSPHATE;

ANIMAL; ARTICLE; DOSE RESPONSE; FEMALE; HISTOLOGY; INTRAVENOUS DRUG ADMINISTRATION; LIVER; MALE; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; RABBIT; RANDOMIZATION; STATISTICS; TIME;

ANIMALS; CONTRAST MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; EDETIC ACID; FEMALE; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; LIVER; MAGNETIC RESONANCE IMAGING; MALE; MANGANESE; PYRIDOXAL PHOSPHATE; RABBITS; RANDOM ALLOCATION; TIME FACTORS;

EID: 0031182270     PISSN: 02841851     EISSN: None     Source Type: Journal    
DOI: 10.1080/02841859709172404     Document Type: Article

References (18)

1. BERNARDINO M. E.: Clinical hepatic imaging with paramagnetic positive enhancers. Magn. Reson. Imaging 22 (1991) 334.
2. BERNARDINO M. E., YOUNG S. W., LEE J. K. & WEINREB J.: Contrast-enhanced magnetic resonance imaging of the liver with Mn-DPDP for known or suspected focal hepatic disease. Invest. Radiol. (1991), 148.
3. BERNARDINO M. E., YOUNG S. W., LEE J. K. & WEINREB J. C.: Hepatic MR imaging with Mn-DPDP Safety, image quality, and sensitivity. Radiology 183 (1992), 53.
4. COLEY B. D., MATTREY R. F., BAKER K. G., PETERSON T. & BURGAN A. R.: MR imaging assessment of experimental hepatic dysfunction with Mn-DPDP. J. Magn. Reson. Imaging 5 (1995), 11.
5. ELIZONDO G., FRETZ C. J., STARK D. D. et al.: Preclinical evaluation of MnDPDP. New paramagnetic hepatobiliary contrast agent for MR imaging. Radiology 178 (1991), 73.
6. GRANT D., ZECH K. & HOLTZ E.: Biodistribution and in vivo stability of manganese dipyridoxyl diphosphate in relation to imaging efficacy. Invest. Radiol. 29 (1994), 249.
7. HAMM B., VOGL T. J., BRANDING G. et al.: Focal liver lesions. MR imaging with Mn-DPDP - initial clinical results in 40 patients. Radiology 182 (1992), 167.
8. LEANDER P., GOLMAN K., KLAVENESS J., HOLTZ E., OLSSON M. & LEUNBACH I.: MRI contrast media for the liver. Efficacy in conditions of acute biliary obstruction. Invest. Radiol. 25 (1990), 1130.
9. LEANDER P., MÅNSSON S., EGE T. & BESJAKOV J.: CT and MR imaging of the liver using liver-specific CM. A comparative study in a tumor model. Acta Radiol. 37 (1996), 242.
10. LIM K. O., STARK D. D. & LEESE P. T., PFEFFERBAUM A., ROCKLAGE S. M. & QUAY S. C.: Hepatobiliary MR imaging. First human experience with MnDPDP. Radiology 178 (1991), 79.
11. NELSON R. C., CHEZMAR J. L., NEWBERRY L. B., MALKO J. A., GEDGAUDAS M. R. & BERNARDINO M. E.: Manganese dipyridoxyl diphosphate. Effect of dose, time, and pulse sequence on hepatic enhancement in rats. Invest. Radiol. 26 (1991), 569.
12. ROCKLAGE S. M., QUAY S. & WORAH D.: MR hepatobiliary imaging with a pyridoxal 5′-phosphate chelate. (Abstract.) Magn. Reson. Imaging 6 (1988), Suppl., p. 19.
13. ROFSKY N. M., WEINREB J. C., BERNARDINO M. E., YOUNG S. W., LEE J. K. & NOZ M. E.: Hepatocellular tumors. Characterization with Mn-DPDP-enhanced MR imaging. Radiology 188 (1993), 53.
14. RUMMENY E., EHRENHEIM C., GEHL H. B. et al.: Manganese-DPDP as a hepatobiliary contrast agent in the magnetic resonance imaging of liver tumors. Results of clinical phase II trials in Germany including 141 patients. Invest. Radiol. 26 (1991), 142.
15. TOFT K. G., HUSTVEDT S. O., GRANT D. et al.: Metabolism and pharmacokinetics of MnDPDP in man. Acta Radiol. 38 (1997), 677.
16. TAUPITZ M., HAMM B., SPEIDEL A., DEIMLING M., BRANDING G. & WOLF K. J.: Multisection FLASH. Method for breath-hold MR imaging of the entire liver. Radiology 183 (1992), 73.
17. YOUNG S. W., BRADLEY B., MULLER H. H. & RUBIN D. L.: Detection of hepatic malignancies using Mn-DPDP (manganese dipyridoxal diphosphate) hepatobiliary MRI contrast agent. Magn. Reson. Imaging 8 (1990), 267.
18. YOUNG S. W., SIMPSON B. B., RATNER A. V., MATKIN C. & CARTER E. A.: MRI measurement of hepatocyte toxicity using the new MRI contrast agent manganese dipyridoxal diphosphate, a manganese/pyridoxal 5-phosphate chelate. Magn. Reson. Med. 10 (1989), 1.